ZH
Zhong Yuan Bio-Technology Holdings Limited
ZHYBF · OTC
$2.02 +0.00% (+$0.00)
Market Cap $35.8M
P/E Ratio 118.31x
Div. Yield -
ROE -
Bulios Fair Price
$1.56
22.8% downside
Current Price
$2.02
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ZHYBF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
0 /100
Expensive P/FCF 89.85x
P/S 15.69x
P/E 118.31x
Growth
74 /100
Growing Rev. growth 11.68%
FCF growth N/A
Book val. growth N/A
Profitability
80 /100
Strong FCF margin 17.47%
Op. margin 11.70%
Gross margin 90.94%
Quality
66 /100
Average ROA 9.54%
Asset turnover 0.72x
ROIC 11.14%
Debt
34 /100
Moderate Int. coverage 19.98x
Net debt/EBITDA 9.15x
Current ratio 0.82x
Stability
5 /100
Unstable Profitable years 1
EPS volatility 2,302.06%
Beta 4.01x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ZHYBF
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Ting Ting Chang
Employees
23
Headquarters
Hong Kong